Concepedia
Statistics
Publications
90
Citations
7.5K
H-Index
45
Active since
1966
Affiliations
National Cancer Institute(Current)
Arizona State University
Frederick National Laboratory for Cancer Research
Drug Discovery Laboratory (Norway)
Gordon M. Cragg is an author at National Cancer Institute specializing in pharmacology, medicine, and drug discovery.
Top concepts
PharmacologyMedicineDrug DiscoveryMedicinal ChemistryNatural SciencesBiochemistryDrug DevelopmentBiologyEngineeringToxicology
Publications per year
1966–2016
HIV inhibitory natural products. Part 7. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum
Yoel Kashman, Kirk R. Gustafson, Ray W. Fuller et al. · Journal of Medicinal Chemistry · 1992 · 546 citations
Biodiversity: A continuing source of novel drug leads
Gordon M. Cragg, David Newman · Pure and Applied Chemistry · 2005 · 394 citations · Full text
Engineering, Secondary Metabolite, Fungal Species +20
Natural Product Drug Discovery in the Next Millennium
Gordon M. Cragg, David Newman · Pharmaceutical Biology · 2001 · 374 citations
Bioorganic Chemistry, Medicinal Chemistry, Microbial Ecology +20
Natural Product Drug Discovery and Development: New Perspectives on International Collaboration
Joseph T. Baker, Robert P. Borris, Brad Carté et al. · Journal of Natural Products · 1995 · 346 citations
Engineering, Genetics, New Perspectives +25
The Taxol Supply Crisis. New NCI Policies for Handling the Large-Scale Production of Novel Natural Product Anticancer and Anti-HIV Agents
Gordon M. Cragg, Saul A. Schepartz, Matthew Suffness et al. · Journal of Natural Products · 1993 · 307 citations
1–5 of 90